XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.3
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes the activity relating to the Company’s market-based stock options for the six-month period ended September 30, 2024:
OptionsWeighted-
Average
Exercise Price
Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
5,445 13.39 — — 
Granted— — — — 
Exercised— — — — 
Forfeited(50)3.13 — — 
Outstanding as of September 30, 2024
5,395 13.487.46$2,293 
Vested as of September 30, 2024
   $ 
The following table summarizes the activity relating to the Company’s stock options, excluding the market-based stock options, for the six-month period ended September 30, 2024:

OptionsWeighted-
Average
Exercise Price
Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
1,979 4.68 — — 
Granted375 4.31 — — 
Exercised— — — — 
Forfeited(45)5.96 — — 
Outstanding as of September 30, 2024
2,309 4.596.82$1,600 
Vested as of September 30, 2024
1,972 4.64 6.33$1,370 
Schedule of Fair Value Valuation Assumptions
The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model reflecting the following weighted-average assumptions:

September 30, 2023September 30, 2024
Expected volatility 55.6 %60.2 %
Expected life of options6.16.5
Risk free interest rate3.87 %4.23 %
Dividend yield— — 
Weighted-average fair value of options granted during the year$1.66$2.66
Schedule of Restricted Stock Activity A summary of all unvested restricted stock for the six-month period ended September 30, 2024 is as follows:
Number of
Unvested Shares
Weighted- Average
Grant Date Fair Value
Unvested, March 31, 2024
1,370 2.68 
Granted54 5.45 
Vested(1,370)2.68 
Forfeited or expired— — 
Unvested, September 30, 2024
54 5.45 
Schedule of Unvested SARs Activities
The following table summarizes the activities for the outstanding SARs:

Number of SARsWeighted-
Average
Exercise Price
Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
— — 
Acquired through MiX Combination5,740 2.61 
Granted— — 
Exercised(677)2.97 
Forfeited(491)2.42 
Outstanding as of September 30, 2024
4,572 2.573.16
Vested as of September 30, 2024
1,420 3.08 1.41$2,710